Top Markets
#1 GEKKO GEKKO +52.86%
#2 ADO Protocol ADO Protocol +38.71%
#3 Helium Helium +36.73%
#4 Pons Pons +27.97%
#5 TENDIES TENDIES +22.63%
#6 龙虾 (Lobster) 龙虾 (Lobster) +22.50%
#7 o1.exchange o1.exchange +18.62%
#8 Main Street Yield Main Street Yield +17.48%
#9 Nillion Nillion +16.95%
#10 Cysic Cysic +16.26%
Coin of the day
GEKKO GEKKO
Settings
Language
ENGLISH
Currency
USD
Theme
China Resources Boya Bio-pharmaceutical Group Co., Ltd. China Resources Boya Bio-pharmaceutical Group Co., Ltd.

China Resources Boya Bio-pharmaceutical Group Co., Ltd.

300294
Rank in Stocks #9112
Established in 1993 and headquartered in Fuzhou, China, China Resources Boya... Established in 1993 and headquartered in Fuzhou, China, China Resources Boya Bio-pharmaceutical Group Co., Ltd. (formerly Boya Bio-pharmaceutical Group Co., Ltd.) is a comprehensive pharmaceutical enterprise operating across China. The company is engaged in the research, development, production, and sale of a diverse portfolio, primarily focusing on blood products, diabetes medications, and various biochemical and chemical pharmaceuticals. Its extensive range of blood-derived products includes human fibrinogen, human albumin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, and freeze-dried intravenous human immunoglobulin. For diabetes management, the company offers metformin hydrochloride (both tablets and enteric-coated versions), pioglitazone hydrochloride dispersible tablets, glimepiride tablets, and calcium dobesilate capsules. Additionally, it produces specialized injections such as compound osteotide, oxytocin, and heparin sodium, which are utilized across numerous medical fields, including general medicine, hepatitis treatment, gynecology, and immunomodulatory applications.
Share Price
$2.16
Last synced: 2026-08-28
Market Cap
$1.09B
Change (1 day)
-0.07%
Change (1 year)
-42.06%
Country
CN
Trade China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)

Category

Healthcare
Operating Margin for China Resources Boya Bio-pharmaceutical Group Co., Ltd. (300294)
Operating Margin as of 2026 TTM: 0.00%
According to China Resources Boya Bio-pharmaceutical Group Co., Ltd. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for China Resources Boya Bio-pharmaceutical Group Co., Ltd. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.